Abbott, St. Jude Medical Post Gains
St. Jude expects full-year profit in the range of $2.30 to $2.32 a share. Analysts, on average, are looking for $2.31 for the year.
After Tuesday's close, Genentech (DNA Quote) announced product sales above expectations, but said a few charges affected GAAP and non-GAAP EPS by about 13 cents collectively. Adjusted profit rose 11% year over year to $863 million, or 81 cents a. Revenue rose 17% to roughly $3.4 billion. The company garnered upgrades from Citigroup and Cowen and Co. on Wednesday. Shares were up 6. 1%, at $83.96.- Loading Comments...
- Loading Comments...
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,406.96 | 1,109.30 | 2,197.85 | 33.31 |
Oil *
78.75
|
|
UP
136.49
|
UP
15.82
|
UP
29.97
|
DOWN
0.98
|
10 Yr
3.33%
SPDR Gold
111.63
|
|
+1.33%
|
+1.45%
|
+1.38%
|
-2.86%
|
Data delayed 20 minutes |














